Search Results - Melbourne Interventional Group

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Utility of the ACC/AHA lesion classification as a predictor of procedural, 30-day and 12-month outcomes in the contemporary percutaneous coronary intervention era.

    Utility of the ACC/AHA lesion classification as a predictor of procedural, 30-day and 12-month outcomes in the contemporary percutaneous coronary intervention era. by Theuerle, J., Yudi, M., Farouque, O., Andrianopoulos, N., Scott, P., Ajani, A., Brennan, Angela, Duffy, S., Reid, Christopher, Clark, D., Melbourne Interventional Group.

    Published 2017
    Get full text
  2. 2
    Pretreatment with dual antiplatelet therapy in patients with ST-elevation myocardial infarction.

    Pretreatment with dual antiplatelet therapy in patients with ST-elevation myocardial infarction. by Yudi, M., Farouque, O., Andrianopoulos, N., Ajani, A., Brennan, A., Lefkovits, J., Reid, Christopher, Chan, W., Duffy, S., Clark, D., Melbourne Interventional Group.

    Published 2017
    Get full text
  3. 3
    Clopidogrel, Prasugrel or Ticagrelor in Patients with Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention.

    Clopidogrel, Prasugrel or Ticagrelor in Patients with Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention. by Yudi, M., Clark, D., Farouque, O., Eccleston, D., Andrianopoulos, N., Duffy, S., Brennan, A., Lefkovits, J., Ramchand, J., Yip, T., Oqueli, E., Reid, Christopher, Ajani, A., Melbourne Interventional Group

    Published 2016
    Get full text

Search Tools: